Trisha Emish named Director of Market Research at KMK Consulting Inc.
KMK Consulting Inc., a leading provider of operational support and analytics services to the pharmaceutical industry for over twenty years, is pleased to announce that Trisha Emish has been named the new Director of Market Research. Trisha has over 25 years’ experience across multiple facets of Marketing and Market Research, including fifteen years of research working […]
KMK Names Shanique Turner as Director of Market Research
Shanique Turner has been named KMK Consulting’s new Director of Market Research MORRISTOWN, NJ, US, August 16, 2022 /EINPresswire.com/ — KMK Consulting Inc. is pleased to announce they have named Shanique Turner as their new Director of Market Research, effective July 2022. She will be working alongside Market Research Principal Dan DeSantis to build and nurture […]
KMK Consulting Inc. Earns 2022 US Great Place to Work Certification™
KMK Consulting Inc is proud to be Certified™ by Great Place to Work® for the second year in a row. KMK Consulting Inc. is proud to be Certified™ by Great Place to Work® for the second year in a row. The prestigious award is based entirely on what current employees say about their experience working at […]
KMK Consulting Welcomes New Market Research Principal, Dan DeSantis
Dan DeSantis joins the team at KMK Consulting as Principal of their Market Research division “There is a unique opportunity here to leverage our expertise in analytics, behavioral economics, and technology to drive integrated, actionable insights to our clients.“— Dan DeSantis, KMK Principal Market Research. He has been named KMK Consulting’s new Principal of Market Research, […]
KMK Consulting, Inc. Earns 2021 Great Place to Work Certification™
KMK is proud to be Certified™ by Great Place to Work® for the first year! The prestigious award is based entirely on what current employees say about their experience working at KMK. This year, 84% of employees said it’s a great place to work – 25 points higher than the average U.S. company. Additionally, 93% of employees […]
Erenumab Study Demonstrates Significantly Reduced Acute Medication Usage and Health Care Utilization for Migraines
A recent study of the fully human monoclonal antibody erenumab was designed to evaluate real-world evidence on the impact of erenumab on acute medication usage and health care utilization (HCRU) among migraine patients. The Health Economics and Outcomes Research analyst team, tasked by Novartis and managed by Lujia Zhou, KMK Consulting, Inc., conducted a retrospective […]
GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma
MORRISTOWN, N.J., March 18, 2020 /PRNewswire/ — In an ongoing series of research conducted by KMK Consulting, Inc. covering Innovation & Customer Value, GSK was ranked as the top company delivering superior customer value and sales force engagement, as well as delivering therapeutic innovation in the asthma market according to pulmonary disease specialists. The research was conducted in February […]
KMK Partners with Major Pharma Company in Recent RWE Study Analyzing Multiple Sclerosis Treatment Costs
KMK partners with a global healthcare company in a real-world evidence study to quantify the healthcare costs associated with Multiple Sclerosis relapse. MORRISTOWN, NEW JERSEY, UNITED STATES, January 14, 2021 /EINPresswire.com/ — People and their loved ones dealing with multiple sclerosis (MS) face many challenges. The disease can cause people’s immune systems to attack their […]
KMK Partners with Pharma Giant to Analyze Switching Costs of Biologic Treatments with Real World Data
KMK Consulting partners with one of the world’s largest Pharmaceutical companies in a real-world evidence study MORRISTOWN, NEW JERSEY, UNITED STATES, November 17, 2020 /EINPresswire.com/ — Real-World Evidence (RWE) plays a significant role in how the pharmaceutical industry brings a brand to market. Every healthcare decision should be informed by the best scientific research derived […]
